iNAP® Granted KFDA, Somnics Makes its debut in South Korea
iNAP® Granted KFDA, Somnics Makes its debut in South Korea
Somnics, Inc. announced that the company has received Korea Medical Device Registration and Approval（KFDA）for iNAP® One Sleep Therapy System, and the company joins forces with LMT Korea Co. Ltd., looking forward to launching the product in the second half of 2022. LMT Korea is one of the leading sleep respiratory diagnostic and treatment equipment providers in South Korea and the exclusive Korea distributor of Lowenstein respirators from Germany. With its comprehensive service coverage and close collaboration with more than 200 medical institutions, LMT has a high market share of CPAP devices in Korea.
“Demand for Sleep Tech services has increased at a rapid pace. ” said Eric, the Vice President of Somnics. “According to the research of NHIS Korea, the medical expenditure for sleep disorders grows at a rate of 25.2% from 2016 to 2020. Therefore, there is a considerable potential for the market.”
iNAP® is a new, patient-preferred, non-surgical device for the treatment of Obstructive Sleep Apnea (OSA) in adults of all severities-mild, moderate, and severe. With the mobile App and cloud-based platform, users can record the information of efficacy and get the treatment outcome for analysis and adjustment. Hence, users of iNAP do not have to go to hospital for treatment, because the online communication between patients and health professionals has been established, especially during the Covid-19 pandemic.
iNAP® Sleep Therapy System has scored medical device licenses and entered the market in lots of areas, including Taiwan, USA, EU, UK, Australia, Hong Kong, Singapore, Thailand and Malaysia, etc. Somnics expects to expand its business portfolio in the East-Asia area and provide a more convenient and comprehensive sleep care treatment for OSA patients.
About Somnics
Somnics Inc. is a medical device company that focuses on developing innovative technologies for the treatment of Obstructive Sleep Apnea (OSA).
Unlike existing OSA-treatment machine that uses Continuous Positive Airway Pressure (CPAP), our product, iNAP® comes with revolutionary therapy system of applying Negative Pressure to oral cavity, provides a simple, more comfortable, and discreet way that allows patients to breath naturally during OSA treatment.
For more information about Somnics, please visit www.somnics.com.https://money.udn.com/money/story/11799/6351647
☛ 了解更多關於iNAP
適當的睡眠溫度：雖然因為天氣寒冷，有不少人會開暖氣讓室溫升高，不過最適宜的睡眠溫度是稍微再涼爽一點的18-22度，在適當的溫度下進入夢鄉，也能提升睡眠品質！